MedPath

Role of markErs in the progreSsion of dIabeteS in Obese paTIeNts

Completed
Conditions
Obese Patients
Registration Number
NCT02934737
Lead Sponsor
University of Pavia
Brief Summary

Obese patients will be enrolled from 2006 to 2014. The progression of diabetes mellitus will be observed (if any). Anthropometric and biochemical parameters will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Obesity (body mass index >/= 30 Kg/m2
  • Normal blood glucose (glycemia < 100 mg/dl)
Exclusion Criteria
  • No exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression of diabetes8 years

evaluation of glycemia during 8 years

Markers of progression of diabetes8 years

Resistin

Anthropometric parameters8 years

Waist circumference; hip circumference; abdominal circumference

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath